Patents

Aastrom holds patents covering strategically important areas of its tissue repair cell (TRC) technology platform, with intellectual property (IP) protection across a broad range of positions in cell therapy and regenerative medicine. Ixmyelocel-T is covered by our patent holdings. To view patent information, follow the links to the U.S. Patent & Trademark Office website provided in the IP Protected column.

Category	Patent Number	IP Protected	Assignee	Expiry Date
Method	8,394,631	Method for manufacture of cell compositions	Aastrom	13-Oct-2027
Method	8,158,122	Method for cell administration of TRC (ixmyelocel-T) to patients	Aastrom	13-Oct-2029
COM	7,871,605	TRC Composition	Aastrom	13-Oct-2029
COM	5,670,147	Ex vivo cell culture composition	Univ of Mich	23-Sep-2014
Device	6,238,908	ARS System	Aastrom	7-Jun-2015
Device	6,228,635	Cassette for ARS	Aastrom	7-Jun-2015
Device	6,096,532	Robot for ARS	Aastrom	7-Jun-2015
Device	6,048,721	Cell growth program for ARS	Aastrom	7-Jun-2015
Device	5,994,129	Cell growth apparatus for ARS	Aastrom	7-Jun-2015
Device	5,985,653	Incubator for ARS	Aastrom	7-Jun-2015
Device	5,688,687	Bioreactor for “mammalian cells”	Aastrom	18-Nov-2014